# Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

> **NCT03132493** · — · COMPLETED · sponsor: **Spanish Lung Cancer Group** · enrollment: 676 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Nivolumab 10 MG/ML

## Key facts

- **NCT ID:** NCT03132493
- **Lead sponsor:** Spanish Lung Cancer Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2017-12-01
- **Final completion:** 2018-09-15
- **Target enrollment:** 676 (ACTUAL)
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03132493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03132493, "Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03132493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*